首页|超声辅助介入治疗联合沙库巴曲缬沙坦钠片治疗老年冠心病合并慢性左心力衰竭患者的效果观察

超声辅助介入治疗联合沙库巴曲缬沙坦钠片治疗老年冠心病合并慢性左心力衰竭患者的效果观察

扫码查看
目的 研究超声辅助介入治疗联合沙库巴曲缬沙坦钠片治疗老年冠心病合并慢性左心力衰竭患者的效果。方法 回顾性分析2019年1月至2020年1月浙江省三门县人民医院收治的确诊冠心病慢性左心力衰竭患者113例,按照治疗方法的不同分为单纯手术组(56例)、联合手术组(57例)。单纯手术组接受超声辅助经桡动脉介入术。联合手术组在单纯手术组基础上联合沙库巴曲缬沙坦钠片治疗。观察比较患者心功能指标、血清炎性因子指标、心脏超声指标、手术时间情况。结果 治疗后,联合手术组患者心率(84±4)次/min、平均动脉压(96±3)mmHg低于单纯手术组[(96±6)次/min,(110±5)mmHg],动脉血氧分压(95±4)mmHg、左心室射血分数(32。3±2。0)%、心搏次数(68。8±4。3)次/min高于单纯手术组[(84±5)mmHg,(35。6±2。1)%,(55。3±4。3)次/min](P<0。05)。治疗后,联合手术组血清炎性因子[C反应蛋白(CRP)(3。1±1。5)mg/ml,肿瘤坏死因子(TNF)-α(15。2±2。3)ng/L,成纤维细胞生长因子-23(FGF-23)(43±6)pg/ml,白细胞介素(IL)-6(8。0±2。0)ng/L]降幅大于单纯手术组[(4。1±1。7)mg/ml,(16。4±2。1)ng/L,(48±6)pg/ml,(8。9±2。5)ng/L],(P<0。05)。治疗后,联合手术组左心室收缩末期内径(LVESD)(35±4)mm、左心室舒张末期内径(LVEDD)(44±4)mm低于单纯手术组[(38±4)mm,(45±4)mm],左心室射血分数(LVEF)(60±4)%高于单纯手术组(57±4)%(P<0。05)。单纯手术组手术时间平均(67±29)min比联合手术组平均手术时间长(58±24)min(t=48。523,P<0。05)。结论 超声辅助介入治疗联合沙库巴曲缬沙坦钠片治疗冠心病慢性左心力衰竭可以降低患者的手术时间,改善患者心功能,降低血清炎性因子水平。
Effects of ultrasound-assisted interventional therapy combined with sackubactril valsartan sodium tablets in the treatment of elderly patients with coronary heart disease and chronic left heart failure
Objective To study the effect of ultrasound-assisted interventional therapy combined with sackubictril valsartan sodium tablets in the treatment of elderly patients with coronary heart disease combined with chronic left heart failure.Methods From January 2019 to January 2020,a total of 113 patients in Sanmen Country People's Hospital with coronary heart disease and chronic left heart failure were selected as study subjects.They were divided into a simple operation group(n=56)and a combined surgery group(n=57).The simple operation group received ultrasound-assisted transradial artery intervention.The combined operation group was treated with sacubitril valsartan sodium tablets on the basis of the treatment in the simple operation group.The cardiac function indexes,serum inflammatory factor indexes,cardiac ultrasound indexes and operation time were observed and compared.Results After treatment,the heart rate and the mean arterial pressure in the combined operation group[(84±4)times/min,(96±3)mmHg]were significantly lower than those in the simple operation group[(96±6)times/min,(110±5)mmHg].Arterial blood oxygen partial pressure,left ventricular ejection fraction,and pulse volume in the combined operation group[(95±4)mmHg,(32.3±2.0)%,(68.8±4.3)times/min]were significantly higher than those in the simple operation group[(84±5)mmHg,(35.6±2.1)%,(55.3±4.3)times/min](P<0.05).After treatment,the reduction of serum inflammatory factors in the combined operation group[(3.1±1.5)mg/ml,(15.2±2.3)ng/L,(43±6)pg/ml,(8.0±2.0)ng/L]was greater than that in the simple operation group[(4.1±1.7)mg/ml,(16.4±2.1)ng/L,(48±6)pg/ml,(8.9±2.5)ng/L],(P<0.05).The values of LVESD and LVEDD in the combined operation group[(35±4)mm,(44±4)mm]were lower than those in the simple operation group[(38±4)mm,(45±4)mm].The value of LVEF in the combined operation group(60±4)%was significantly higher than that of the simple operation group(57±4)%(P<0.05).The average operation time of the simple operation group was(67±29)min,while the average operation time of the combined operation group was(58±24)min(t=48.523,P<0.05).Conclusion ltrasound-assisted interventional therapy combined with sakubactril valsartan sodium tablets in the treatment of chronic left heart failure and coronary heart disease can reduce the operation time,significantly improve the cardiac function index and reduce the level of serum inflammatory factors,which is worthy of application.

UltrasonographyEndovascular proceduresCoronary diseaseHeart failureHeart function

吴献献、张青青

展开 >

三门县人民医院超声科,浙江台州 317100

超声检查 血管内操作 冠心病 心力衰竭 心功能

2024

中国药物与临床
中国医院协会

中国药物与临床

影响因子:0.846
ISSN:1671-2560
年,卷(期):2024.24(12)